A. C. Van Loenen

1.3k total citations
40 papers, 958 citations indexed

About

A. C. Van Loenen is a scholar working on Pharmacology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, A. C. Van Loenen has authored 40 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Pathology and Forensic Medicine and 5 papers in Physiology. Recurrent topics in A. C. Van Loenen's work include Multiple Sclerosis Research Studies (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Nausea and vomiting management (2 papers). A. C. Van Loenen is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Nausea and vomiting management (2 papers). A. C. Van Loenen collaborates with scholars based in Netherlands, Italy and Belgium. A. C. Van Loenen's co-authors include Pim N.J. Langendijk, F.W. Bertelsmann, D. de Hoop, C. Nieboer, CH Polman, W. W. A. Zuurmond, J. J. de Lange, H.A.M. van Diemen, J.C. Koetsier and Chris H. Polman and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Journal of the American Academy of Dermatology.

In The Last Decade

A. C. Van Loenen

33 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. C. Van Loenen Netherlands 16 307 245 167 147 147 40 958
Yu‐Duan Tsai Taiwan 18 155 0.5× 288 1.2× 44 0.3× 25 0.2× 35 0.2× 32 900
C. Mclean Australia 19 65 0.2× 104 0.4× 99 0.6× 254 1.7× 35 0.2× 47 1.0k
Yasuo Ito Japan 25 86 0.3× 63 0.3× 153 0.9× 21 0.1× 68 0.5× 138 1.9k
John T. Sullivan United States 24 295 1.0× 132 0.5× 191 1.1× 13 0.1× 77 0.5× 52 1.8k
Taotao Liu China 20 145 0.5× 56 0.2× 111 0.7× 38 0.3× 39 0.3× 76 1.1k
Andreas Alt Germany 19 89 0.3× 465 1.9× 107 0.6× 34 0.2× 16 0.1× 37 1.0k
Rong Jiang China 22 45 0.1× 535 2.2× 98 0.6× 58 0.4× 85 0.6× 58 1.5k
Lennart Nässberger Sweden 18 112 0.4× 102 0.4× 202 1.2× 8 0.1× 219 1.5× 77 1.5k
J. H. Tyrer Australia 18 69 0.2× 61 0.2× 114 0.7× 47 0.3× 15 0.1× 58 1.1k
I Caruso Italy 15 553 1.8× 31 0.1× 112 0.7× 25 0.2× 88 0.6× 48 1.1k

Countries citing papers authored by A. C. Van Loenen

Since Specialization
Citations

This map shows the geographic impact of A. C. Van Loenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. C. Van Loenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. C. Van Loenen more than expected).

Fields of papers citing papers by A. C. Van Loenen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. C. Van Loenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. C. Van Loenen. The network helps show where A. C. Van Loenen may publish in the future.

Co-authorship network of co-authors of A. C. Van Loenen

This figure shows the co-authorship network connecting the top 25 collaborators of A. C. Van Loenen. A scholar is included among the top collaborators of A. C. Van Loenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. C. Van Loenen. A. C. Van Loenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franssen, Eric J. F., Peter W.A. Kunst, Pierre M. Bet, et al.. (2003). Toxicokinetics of Nortriptyline and Amitriptyline: Two Case Reports. Therapeutic Drug Monitoring. 25(2). 248–251. 18 indexed citations
2.
Huijgens, P.C., A. M. Simoons‐Smit, A. C. Van Loenen, et al.. (1999). Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.. Journal of Clinical Pathology. 52(5). 376–380. 57 indexed citations
3.
Loenen, A. C. Van, et al.. (1997). Ziekte van Alzheimer: nieuwe inzichten in de farma-cotherapie. Data Archiving and Networked Services (DANS). 132. 1108–1116.
4.
Zuurmond, W. W. A., et al.. (1996). Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty cream. Acta Anaesthesiologica Scandinavica. 40(3). 364–367. 143 indexed citations
5.
Loenen, A. C. Van, et al.. (1995). Glutaraldehyde: Current Status and Uses. Infection Control and Hospital Epidemiology. 16(11). 621–622. 2 indexed citations
6.
Emmen, Harry, et al.. (1994). The effects of 4‐aminopyridine on cognitive function in patients with multiple sclerosis. Neurology. 44(9). 1701–1701. 68 indexed citations
7.
Polman, Chris H., F.W. Bertelsmann, Reneé de Waal, et al.. (1994). 4-Aminopyridine Is Superior to 3,4-Diaminopyridine in the Treatment of Patients With Multiple Sclerosis. Archives of Neurology. 51(11). 1136–1139. 47 indexed citations
8.
9.
Diemen, H.A.M. van, Chris H. Polman, J.C. Koetsier, et al.. (1993). 4-Aminopyridine in Patients with Multiple Sclerosis. Clinical Neuropharmacology. 16(3). 195–204. 69 indexed citations
10.
Diemen, H.A.M. van, Chris H. Polman, J. J. P. Nauta, et al.. (1993). 4-Aminopyridine induces functional improvement in multiple sclerosis patients: A neurophysiological study. Journal of the Neurological Sciences. 116(2). 220–226. 45 indexed citations
11.
Loenen, A. C. Van, John Wagstaff, Ellen Meijer, et al.. (1992). Suramin: rapid loading and weekly maintenance regimens for cancer patients.. Journal of Clinical Oncology. 10(11). 1788–1794. 16 indexed citations
12.
Loenen, A. C. Van, et al.. (1991). Antibiotic concentrations in the groin wound after vascular prosthetic implantation. Pharmacy World & Science. 13(4). 179–181. 1 indexed citations
13.
Nieboer, C., D. de Hoop, Pim N.J. Langendijk, A. C. Van Loenen, & J. W. Gubbels. (1990). Fumaric Acid Therapy in Psoriasis: A Double-Blind Comparison between Fumaric Acid Compound Therapy and Monotherapy with Dimethylfumaric Acid Ester. Dermatology. 181(1). 33–37. 69 indexed citations
14.
Loenen, A. C. Van, et al.. (1990). Phase I/II study of suramin in hormone resistant metastatic prostate cancer. European Journal of Cancer and Clinical Oncology. 26(2). 185–185. 1 indexed citations
15.
Groeningen, C.J. van, H.E. Gall, A. C. Van Loenen, et al.. (1989). Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesis.. PubMed. 35(5-6). 283–94. 1 indexed citations
16.
Nieboer, C., D. de Hoop, A. C. Van Loenen, Pim N.J. Langendijk, & E. van Dijk. (1989). Systemic therapy with fumaric acid derivates: New possibilities in the treatment of psoriasis. Journal of the American Academy of Dermatology. 20(4). 601–608. 82 indexed citations
17.
Loenen, A. C. Van, et al.. (1987). Secretion of cefoxitin in breast milk following short-term prophylactic administration in caesarean section. European Journal of Obstetrics & Gynecology and Reproductive Biology. 25(4). 299–302. 11 indexed citations
18.
Meer, Y. G. Van Der, et al.. (1982). Plasma progesterone levels after using high dose suppositories. A preliminary report. Pharmacy World & Science. 4(5). 135–136. 11 indexed citations
19.
Bijsterveld, O.P. van, et al.. (1979). Effect of Pilocarpine on the Intraocular Pressure after Water-Loading in Rabbits. Ophthalmic Research. 11(1). 13–18. 2 indexed citations
20.
Mouton, R. P., et al.. (1976). Relationship between antibiotic consumption and frequency of antibiotic resistance of four pathogens—a seven-year survey. Journal of Antimicrobial Chemotherapy. 2(1). 9–19. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu‐Duan Tsai Breakdown of academic impact, for papers by C. Mclean Breakdown of academic impact, for papers by Yasuo Ito Breakdown of academic impact, for papers by John T. Sullivan Breakdown of academic impact, for papers by Taotao Liu Breakdown of academic impact, for papers by Andreas Alt Breakdown of academic impact, for papers by Rong Jiang Breakdown of academic impact, for papers by Lennart Nässberger Breakdown of academic impact, for papers by J. H. Tyrer Breakdown of academic impact, for papers by I Caruso
Rankless by CCL
2026